Electrophysiology provides a real-time readout of neural functions and network capability in different brain states, on temporal (fractions of milliseconds) and spatial (micro, meso, and macro) scales unmet by other methodologies. However, current international guidelines do not endorse the use of electroencephalographic (EEG)/magnetoencephalographic (MEG) biomarkers in clinical trials performed in patients with Alzheimer's disease (AD), despite a surge in recent validated evidence. This position paper of the ISTAART Electrophysiology Professional Interest Area endorses consolidated and translational electrophysiological techniques applied to both experimental animal models of AD and patients, to probe the effects of AD neuropathology (i.e., brain amyloidosis, tauopathy, and neurodegeneration) on neurophysiological mechanisms underpinning neural excitation/inhibition and neurotransmission as well as brain network dynamics, synchronization, and functional connectivity, reflecting thalamocortical and corticocortical residual capacity. Converging evidence shows relationships between abnormalities in EEG/MEG markers and cognitive deficits in groups of AD patients at different disease stages. The supporting evidence for the application of electrophysiology in AD clinical research as well as drug discovery pathways warrants an international initiative to include the use of EEG/MEG biomarkers in the main multicentric projects planned in AD patients, to produce conclusive findings challenging the present regulatory requirements and guidelines for AD studies.
Keywords: Alzheimer's disease (AD); Electroencephalography and magnetoencephalography (EEG and MEG); Event-related potentials and magnetic fields; Preclinical and clinical research; Resting-state condition; The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART).
Copyright © 2019 Elsevier Inc. All rights reserved.
Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms.Int J Psychophysiol. 2016 May;103:88-102. doi: 10.1016/j.ijpsycho.2015.02.008. Epub 2015 Feb 7. Int J Psychophysiol. 2016. PMID: 25660305 Review.
Short timescale abnormalities in the states of spontaneous synchrony in the functional neural networks in Alzheimer's disease.Neuroimage Clin. 2018 May 22;20:128-152. doi: 10.1016/j.nicl.2018.05.028. eCollection 2018. Neuroimage Clin. 2018. PMID: 30094163 Free PMC article.
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.J Prev Alzheimers Dis. 2014 Dec;1(3):181-202. doi: 10.14283/jpad.2014.32. J Prev Alzheimers Dis. 2014. PMID: 26478889 Free PMC article.
Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses.Suppl Clin Neurophysiol. 2013;62:237-73. doi: 10.1016/b978-0-7020-5307-8.00020-x. Suppl Clin Neurophysiol. 2013. PMID: 24053044 Review.
Magnetoencephalography applied to the study of Alzheimer's disease.Prog Mol Biol Transl Sci. 2019;165:25-61. doi: 10.1016/bs.pmbts.2019.04.007. Epub 2019 May 23. Prog Mol Biol Transl Sci. 2019. PMID: 31481165